Our mission is to leverage AI & Deep Tech to Democratize access to quality healthcare for everyone
The Future of Healthcare with AI
Artificial Intelligence is redefining the future of healthcare. By integrating AI into healthcare ecosystems, the industry is moving from reactive to predictive care models, early detection, personalized therapies, and more efficient resource utilization.
Early detection
AI can analyze vast amount medical imaging, genetic data, and patient histories to detect anomalies far earlier than traditional diagnostics.
Precision imaging
AI-powered image segmentation and pattern recognition tools enhance radiology, pathology, and ophthalmology diagnostics.
AI is not just augmenting
Healthcare, it’s repurposing it. From drug discovery to virtual nursing assistants, AI innovation is reshaping the care continuum across hospitals, research labs, and home-based environments
Virtual diagnostics:
Clinical chatbots and triage systems assist in preliminary assessments, improving accessibility and speed.
Clinical automation:
AI integrates with Electronic Health Records (EHRs) to reduce administrative burdens, allowing clinicians to focus more on patient care.
Personalized treatment
AI algorithms tailor medications and therapies based on genetic and lifestyle factors, supporting precision medicine.
Market Need
Current diagnostic workflows depend heavily on radiologists’ manual MRI interpretation. This process is slow, prone to human error, and inadequate for early-stage or complex tumor cases—leading to delayed treatments, higher mortality, and rising healthcare costs. With the global cancer burden projected to rise by 47% by 2040, scalable AI-driven diagnostic solutions are critical to bridge the gap. Rapid, accurate, and scalable diagnostic solutions are urgently required to address increasing global cancer burdens.
Clinical Impact
TumorXpert’s high diagnostic precision enables faster, more targeted interventions, increasing survival rates and reducing long-term neurological impairment in patients.
Operational Efficiency
Automated triaging reduces the workload on specialized radiologists, empowering primary care and district health centers to handle advanced diagnosis, thus mitigating staff shortages and urban-rural disparities.
Economic Value
Early, accurate diagnosis reduces repeat imaging, misdiagnosis costs, and late-stage treatment expenses.
Wider Coverage and full-blown diagnosis solution for all type of Tumor/ Cancer:
Foundation model will be leverage and enable similar diagnosis for all other type of cancers – skin/ Lungs/ Breast / stomach/ throat etc
Scalability & Accessibility
Secured cloud-ready, hardware-light deployment ensures rapid adoption across government hospitals, rural health centers, and global facilities with minimal IT investment. This allows rapid deployment across healthcare facilities with minimal IT investment, including public hospitals and rural clinics.
A revolutionary approach solving Clinical Diagnosis with Combines power of accuracy (ML) with trust (Symbolic AI), filled Patent for TumorXpert™
The biggest issue in Clinical diagnosis, the sensitivity–specificity trade-off is deeply ingrained in conventional statistical and probabilistic approaches to AI/ML in diagnostic or classification contexts. Typically, tuning a model to increase sensitivity (true positive rate) leads to more false positives (lower specificity), and vice versa. On other hand, Symbolic AI focus on explicit knowledge representation and logical reasoning rather than statistical patterns in data, struggle to handle novel situations and can’t discover hidden pattern.
Hence NeuraXion Labs, developed revolutionary approach TumorXpert™ is a hybrid artificial intelligence approach that combines the strengths of two historically distinct AI paradigms: neural networks and symbolic AI. Combine deep learning (pattern recognition) with symbolic reasoning (logic/knowledge graphs). Symbolic constraints can rule out biologically or clinically implausible predictions, boosting both sensitivity and specificity simultaneously.
Value Proposition and Impact
- Clinical Impact
- Operational Efficiency
- Economic Value
- Wider Coverage and full-blown diagnosis solution for all type of Tumor/ Cancer
- Scalability & Accessibility:
Scientific & Technological Edge
- Hybrid AI: Fusion of Hybrid AI with Deep Tech
- Explainable AI :
- Validated Innovation:
- Wider Research –
- Proven Outcomes:
See it in Action
NeuraXion Labs, the first product derived from our platform, is a clinical decision support tool that enables automated lung cancer screening.
Validated on +2,000 real cases from LIDC & Israeli hospitals databases and in the Assuta clinical study.
TumorXpert — fast, explainable AI for multimodal brain-tumor detection, molecular prediction, and intraoperative decision support.
TumorXpert offers a suite of powerful features designed to enhance diagnostic accuracy and efficiency.
Transformer and foundation-model architectures.
Transformers and large visual models are being applied to multi-sequence MRI and to combine modalities (histology, imaging, clinical) for better classification, segmentation, and prognostics
Radiogenomics — predicting molecular markers from imaging
Deep learning + radiomics pipelines can predict IDH/TERT/other mutation status and correlate imaging features with genomics, potentially reducing need for invasive testing and enabling precision therapy planning
Enabling Timely Intervention in Stroke Care
Receive diagnostic reports within minutes, allowing for prompt intervention and improved patient care.
Our Pipeline
Brain cancer
Ovarian cancer
Colon cancer
Breast cancer
Prostate cancer
Lungs cancer
What TumorXpert does (value)
Discover our latest innovations, achievements, and media highlights.
